131 Oyster Point Blvd. Suite 200
South San Francisco, CA 94080
6 articles with Ambys Medicines
-- Former GRAIL CEO and Roche/Genentech senior executive brings extensive product development and commercialization expertise to liver therapeutics pioneer -- SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Ambys Medicines, a cell and gene therapy company focused on advancing novel treatments to restore and regenerate liver function, today announced the appointment of Jennifer Cook to its Board of Directors. A highly respected biotechnology and
Check out this article for the impacts that Biotech Bay companies are experiencing due to COVID-19.
Biotech and pharma companies tap new members of executive leadership teams and boards.
Ambys Medicines Appoints Deidre Roniger as Senior Vice President of Corporate Development and Amanda Valentino as Chief People Officer
Genentech alumna to lead Ambys’ business strategy and growth initiatives to support company’s focus on pioneering regenerative medicine for advanced liver diseases
BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.
Company pursuing novel modalities including cell and gene therapies to regenerate the liver and restore liver function across multiple liver diseases